Predicine

Predicine is a global molecular insights company that is committed to advancing precision medicine in oncology and infectious diseases. Predicine is developing a proprietary cell-free DNA- and cell-free RNA-based liquid biopsy technology enabling minimally invasive molecular diagnosis for treatment selection, therapy monitoring, and minimal residual disease and early cancer detection. The company has a portfolio of blood-, urine- and tissue-based diagnostic assays for oncology as well as assays for infectious diseases. Through its business operations in Silicon Valley, Houston, Chicago, Los Angeles, Shanghai, Berlin, Singapore, Beijing, Suzhou, Harbin, and Boston, Predicine partners with leading biopharma companies, institutions, and governments to support personalized healthcare on a global scale.